Pharmacological treatments including 6-thioguanine and cyclosporine A, utilized to improve colitis outcomes in mice, effectively reduced circulating SAA levels (229), as did administration of Bacillus subtilis spores as a probiotic (230). This evidence concerns the gene SAA1 and colitis.